MPO and colitis: Meanwhile, 20 mg/kg CK and 100 mg/kg BBR treatment reduced the MPO by 705.3±11.27 mU/g (p<0.001) and 558.3±30.71 mU/g (p<0.001) in severe colitis mice compared to the model group, respectively (Fig. 2A).